Kidney cancer clinical trials: What you need to know

In this article, Deb Maskens, founder of Kidney Cancer Canada and board director of the International Kidney Cancer Coalition (IKCC) recommends that patients with kidney cancer should be thinking about clinical trials at every step of their journey, not just after a line of therapy has stopped working for them. Ms Maskens, an advanced kidney […]

read more

First ever World Kidney Cancer Day highlights the risks associated with kidney cancer – TODAY

Kidney cancer is a serious and deadly disease that affects hundreds of thousands of people worldwide and is resulting in a growing global burden on health care systems, as well as patients and families whose lives are changed forever by the disease. The global incidence of kidney cancer is predicted to rise 22 percent by […]

read more
Showing all 2 results